Inter-individual differences in cognitive abilities in normal individuals and patients with schizophrenia have been associated with variations in the DTNBP1 gene, encoding dysbindin-1 protein (Dys), which is involved in schizophrenia neuropathology and cognitive function during treatment with antipsychotic drugs [8–10]. The gene discussed is DTNBP1; the disease is schizophrenia.